Sanara MedTech Inc. announced the appointment of Seth Yon as President and Chief Executive Officer, effective September 15, 2025.
Seth Yon will be succeeding Ron Nixon, who will continue to serve as Executive Chairman of the company.
The transition in leadership is part of the company's strategic initiative to position itself for future success in the markets it serves.
Leadership Transition
Seth Yon appointed as President and Chief Executive Officer, succeeding Ron Nixon.
Strategic Growth
Company achieved annual net revenue growth of 53% under Seth Yon's leadership in the past three fiscal years.
Market Focus
Sanara MedTech focuses on developing and commercializing transformative technologies in surgical, chronic wound, and skin markets.
Experienced Leadership
Seth Yon brings 27 years of experience in the healthcare industry to his new role as CEO.
- The appointment of Seth Yon reflects the company's confidence in his leadership abilities and strategic vision.
- Sanara MedTech aims to continue its growth trajectory and deliver value to stakeholders under Seth Yon's direction.
The appointment of Seth Yon as President and CEO marks a significant milestone for Sanara MedTech Inc. The company is now poised to leverage his experience and expertise to drive innovation and growth in the healthcare sector.